Internet-Based Vestibular Rehab Beneficial for Dizziness

This article originally appeared here.
Share this content:
Internet-Based Vestibular Rehab Beneficial for Dizziness
Internet-Based Vestibular Rehab Beneficial for Dizziness

TUESDAY, May 9, 2017 (HealthDay News) -- Internet-based vestibular rehabilitation reduces dizziness for adults aged 50 years or older, according to a study published in the May/June issue of the Annals of Family Medicine.

Adam W.A. Geraghty, Ph.D., from the University of Southampton in the United Kingdom, and colleagues enrolled patients aged 50 years and older with current dizziness exacerbated by head movements. Two hundred ninety-six patients were randomized to either usual care or an intervention group that accessed an automated internet-based program teaching vestibular rehabilitation exercises and suggesting cognitive behavioral management strategies. The Vertigo Symptom Scale-Short Form (VSS-SF) was used to measure dizziness at baseline, three months, and six months.

Overall, 250 and 230 patients completed the VSS-SF at three and six months. The researchers found that the internet-based vestibular rehabilitation group had significantly less dizziness on the VSS-SF at three and six months, compared with the usual care group (difference, 2.75 and 2.26 points, respectively). The internet-based vestibular rehabilitation group also had significantly lower dizziness-related disability at three and six months (difference, 6.15 and 5.58 points, respectively).

"Internet-based vestibular rehabilitation reduces dizziness and dizziness-related disability in older primary care patients without requiring clinical support," the authors write. "This intervention has potential for wide application in community settings."

Abstract
Full Text

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths